Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HP802-247 Pharmacodynamic Study in Venous Leg Ulcers
NCT02154087Phase 2Terminated
- Sponsor
- Healthpoint Biotherapeutics
- Start
- Jul 2014
- Primary completion
- Jul 2015
- Modality
- Implantable Devices, Implantable Hydrogels, Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of HP-802-247 in venous leg ulcer (VLU), sponsored by Healthpoint Biotherapeutics. Started Jul 2014; status: terminated.
02
Drugs
HP-802-247
03
Conditions
venous leg ulcer (VLU)
Beyond the preview
Go deeper on NCT02154087.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02154087.